Promethera Biosciences Treats First Patients with Promethera® HepaStemPhase I/II study designed to evaluate the ability of liver progenitor cells to restore a missing enzyme function in liver-based metabolic diseases.
Mucosis Announces Positive Proof-Of-Concept Data for Mimopath® Platform in HumansMimopath®-based vaccines are able to produce balanced immune responses in both circulating blood and the respiratory tract.
New Muscular Dystrophy Treatment Approach Developed Using Human Stem CellsNew process makes the production of human muscle cells from stem cells efficient and effective.
Mucosis Announces Publication of Preclinical Data of Novel Influenza VaccinesMucosally administered Mimopath-based influenza vaccine protects against both homologous and heterologous challenge.
Idera Pharmaceuticals Announces Top-line Results from Phase 2 Clinical TrialIMO-2055 to be used in treatment of patients with advanced head and neck cancer.
Agent Reduces Autism-like Behaviors in MiceBoosts sociability, quells repetitiveness - NIH study.
Adocia Reports Positive Phase II Clinical Results for the Treatment of Diabetic Foot UlcerAdocia’s spray formulation of PDGF-BB, combined with BioChaperone®, has been evaluated versus Regranex®, gel of PDGF-BB.
New Classification Criteria Released for Research on Sjogren's SyndromeNIH-supported alliance validates classification criteria for condition based on objective tests.
NIH Study to Test Treatment for Fatty Liver Disease in ChildrenNIH researchers to find out fatty liver disease diagnosis with cysteamine in CyNCh trial.
Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of EntinostatDrug studied in combination with Lapatinib in HER2-positive metastatic breast cancer.
